All News

Exacerbation history alone is unlikely to provide clinical utility for predicting future COPD exacerbations and could be associated with a risk of harm, according to new analysis.

How to keep family planning conversations in primary care? First, you have to have them, says UC San Francisco professor of family community medicine, Christine Dehlendorf, MD, MAS.

Overall dyspnea was the most common symptom of long COVID in the first year after infection, according to the nationwide retrospective cohort study.

Clinician-directed conversations on contraception and family planning remove patients from the center of the visit which is where must be in a shared decision-making model.

In a study of 874 adults, more women were diagnosed with chronic cluster headache and experienced longer attacks compared with men.

Your daily dose of clinical news you may have missed.

For each cardiometabolic disease, the risk of all-cause dementia rose by 42%; the risk rose 26% for Alzheimer disease and 64% for vascular dementia. Temporal onset and genetics play key roles.

US News and World Report released its annual “Best Diets” rankings for 2023. Out of nearly 40 of the most popular diets ranked by health experts, these 10 came out on top.

The 13 Key Action Steps in the AAP's landmark obesity guidelines reflect more than a decade of research on evaluation and treatment of the disease in children and adolescents.

Diabetes cases in the US among those younger than age 20 years, if left unchecked, are projected to increase by more than 600% by 2060, according to new projections.

Get a quick look at 15 of the many FDA-approved drugs in 2022 for conditions commonly seen in primary care.

Adolescents with more positive psychological assets were more likely to have good cardiometabolic health 2 decades later, and associations were stronger for Black youth.

A global prevalence of osteoporosis among persons with T2D of more than 25% calls for greater focus on screening for and managing the bone loss disease in this population.

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Mayo Clinic's Andres Acosta, MD, PhD.

Approval of lecanemab under FDA's accelerated pathway requires the company to provide phase 4 study evidence to confirm the agent's clinical effect.

If approved, nirsevimab would be the first single-dose RSV preventative option for the broad newborn and infant population in the US.

Your daily dose of clinical news you may have missed.

Adherence to several different healthy eating patterns was associated with reduced risk for all- and specific-cause mortality in a large prospective cohort study with 36 years of follow-up.